Literature DB >> 26941559

Is the medical use of cannabis a therapeutic option for children?

Michael J Rieder.   

Abstract

Cannabis is a psychoactive compound with a long history of recreational and therapeutic use. Current considerations regarding cannabis use for medical purposes in children have been stimulated by recent case reports describing its beneficial effect with refractory epilepsy. Overall, there are insufficient data to support either the efficacy or safety of cannabis use for any indications in children, and an increasing body of data suggests possible harm, most importantly in specific conditions. The potential for cannabis as a therapeutic agent must be evaluated carefully for both efficacy and safety in treating specific paediatric health conditions. Smoking is not an acceptable mode of drug delivery for children. The use of cannabis for medical purposes in specific cases should not be construed as a justification for recreational cannabis use by adolescents. Recommendations for therapeutic use in exceptional paediatric cases are offered, always providing that this treatment course is carefully evaluated in individuals and in ongoing, well-designed research studies to determine safety and efficacy.

Entities:  

Keywords:  Cannabinoids; Children; Epilepsy; Medical marijuana; Nabiximols; Smoking

Year:  2016        PMID: 26941559      PMCID: PMC4758425          DOI: 10.1093/pch/21.1.31

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  28 in total

1.  Impact of ADHD and cannabis use on executive functioning in young adults.

Authors:  Leanne Tamm; Jeffery N Epstein; Krista M Lisdahl; Brooke Molina; Susan Tapert; Stephen P Hinshaw; L Eugene Arnold; Katerina Velanova; Howard Abikoff; James M Swanson
Journal:  Drug Alcohol Depend       Date:  2013-08-11       Impact factor: 4.492

2.  The case for medical marijuana in epilepsy.

Authors:  Edward Maa; Paige Figi
Journal:  Epilepsia       Date:  2014-05-22       Impact factor: 5.864

Review 3.  Adverse health effects of non-medical cannabis use.

Authors:  Wayne Hall; Louisa Degenhardt
Journal:  Lancet       Date:  2009-10-17       Impact factor: 79.321

4.  Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.

Authors:  Marta Di Forti; Arianna Marconi; Elena Carra; Sara Fraietta; Antonella Trotta; Matteo Bonomo; Francesca Bianconi; Poonam Gardner-Sood; Jennifer O'Connor; Manuela Russo; Simona A Stilo; Tiago Reis Marques; Valeria Mondelli; Paola Dazzan; Carmine Pariante; Anthony S David; Fiona Gaughran; Zerrin Atakan; Conrad Iyegbe; John Powell; Craig Morgan; Michael Lynskey; Robin M Murray
Journal:  Lancet Psychiatry       Date:  2015-02-25       Impact factor: 27.083

5.  Improving medicines for children in Canada. Findings of the expert panel on therapeutic products for infants, children and youth.

Authors:  Gideon Koren
Journal:  J Popul Ther Clin Pharmacol       Date:  2013-12-01

Review 6.  Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice.

Authors:  Scott E Hadland; John R Knight; Sion K Harris
Journal:  J Dev Behav Pediatr       Date:  2015 Feb-Mar       Impact factor: 2.225

7.  Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients.

Authors:  Derick T Wade; Petra Makela; Philip Robson; Heather House; Cynthia Bateman
Journal:  Mult Scler       Date:  2004-08       Impact factor: 6.312

8.  Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway.

Authors:  Giuseppe Tortoriello; Claudia V Morris; Alan Alpar; Janos Fuzik; Sally L Shirran; Daniela Calvigioni; Erik Keimpema; Catherine H Botting; Kirstin Reinecke; Thomas Herdegen; Michael Courtney; Yasmin L Hurd; Tibor Harkany
Journal:  EMBO J       Date:  2014-01-27       Impact factor: 11.598

9.  The burden of disease attributable to cannabis use in Canada in 2012.

Authors:  Sameer Imtiaz; Kevin D Shield; Michael Roerecke; Joyce Cheng; Svetlana Popova; Paul Kurdyak; Benedikt Fischer; Jürgen Rehm
Journal:  Addiction       Date:  2016-01-05       Impact factor: 6.526

10.  Biologically active cannabinoids from high-potency Cannabis sativa.

Authors:  Mohamed M Radwan; Mahmoud A Elsohly; Desmond Slade; Safwat A Ahmed; Ikhlas A Khan; Samir A Ross
Journal:  J Nat Prod       Date:  2009-05-22       Impact factor: 4.050

View more
  11 in total

Review 1.  Nutraceuticals and Behavioral Therapy for Headache.

Authors:  Rebecca Barmherzig; Thilinie Rajapakse
Journal:  Curr Neurol Neurosci Rep       Date:  2021-05-10       Impact factor: 5.081

2.  Authorizing medical cannabis for children.

Authors:  Michael Rieder
Journal:  Paediatr Child Health       Date:  2020-06-15       Impact factor: 2.253

3.  Considerations for clinical trials to study cannabinoids in Canadian children with neurologic disorders.

Authors:  Lauren E Kelly; Anne Junker
Journal:  CMAJ       Date:  2018-08-27       Impact factor: 8.262

4.  Cannabis and Canada's children and youth.

Authors:  Christina N Grant; Richard E Bélanger
Journal:  Paediatr Child Health       Date:  2017-05-03       Impact factor: 2.253

Review 5.  Post-diagnostic management and follow-up care for autism spectrum disorder.

Authors:  Angie Ip; Lonnie Zwaigenbaum; Jessica A Brian
Journal:  Paediatr Child Health       Date:  2019-10-24       Impact factor: 2.253

6.  Cannabis Use for Therapeutic Purposes by Children and Youth at a Tertiary Teaching Hospital in Canada: A Retrospective Chart Review.

Authors:  Régis Vaillancourt; Maria Moreno; Annie Pouliot; Erick Sell
Journal:  Can J Hosp Pharm       Date:  2020-04-01

7.  Cannabis: Does it have a medicinal value?

Authors:  Aniruddh P Behere; Prakash B Behere; T S Sathyanarayana Rao
Journal:  Indian J Psychiatry       Date:  2017 Jul-Sep       Impact factor: 1.759

8.  Cannabis for the treatment of paediatric epilepsy? An update for Canadian paediatricians.

Authors:  Richard James Huntsman; Richard Tang-Wai; Bryan Acton; Jane Alcorn; Andrew William Lyon; Darrell David Mousseau; Blair Seifert; Robert Laprairie; Erin Prosser-Loose; Lumir Ondrej Hanuš
Journal:  Paediatr Child Health       Date:  2018-04-05       Impact factor: 2.253

9.  Dronabinol Prescribing and Exposure Among Children and Young Adults Diagnosed with Cancer.

Authors:  Joseph E Rower; Amber D King; Diana Wilkins; Jacob Wilkes; Venkata Yellepeddi; Luke Maese; Richard S Lemons; Jonathan E Constance
Journal:  J Adolesc Young Adult Oncol       Date:  2020-07-14       Impact factor: 2.223

10.  Children and Youth Who Use Cannabis for Pain Relief: Benefits, Risks, and Perceptions.

Authors:  Julia J Woo; Emma A van Reekum; Tea Rosic; Zainab Samaan
Journal:  Adolesc Health Med Ther       Date:  2020-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.